Streetbeat News

Analyst Ratings

MRNA

Recent options trading activity for Moderna (NASDAQ:MRNA) shows a bearish sentiment among large investors, with 63% of trades being bearish. The price target for MRNA is between $69.0 and $160.0. Analysts have mixed ratings, with an average target price of $83.33.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:15 pm

NXT

Jefferies has initiated coverage on NEXTracker with a Hold rating and set a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:15 pm

ERJ

Embraer shares rise as TD Cown upgrades the stock from Hold to Buy, increasing the price target from $26 to $41.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:14 pm

TLN

Guggenheim has initiated coverage on Talen Energy with a Buy rating and set a price target of $169. This suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:14 pm

GEV

Jefferies has initiated coverage on GE Vernova with a Buy rating and set a price target of $261.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:12 pm

PD

TD Cowen analyst J. Derrick Wood maintains a Hold rating on PagerDuty (NYSE:PD) but lowers the price target from $23 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:10 pm

MITK

Jefferies analyst Surinder Thind has downgraded Mitek Systems from Buy to Hold and reduced the price target from $17 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:07 pm

GTLB

TD Cowen analyst J. Derrick Wood maintains a Buy rating on GitLab (NASDAQ:GTLB) and raises the price target from $58 to $63.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:05 pm

SMCI

Super Micro Computer's stock is trading lower following a downgrade by Barclays from Overweight to Equal-Weight, with a reduced price target from $693 to $438.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:04 pm

ASML

UBS analyst Francois-Xavier Bouvignies has downgraded ASML Holding from Buy to Neutral, indicating a change in the investment outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:03 pm